SAFETY OF TUMOR NECROSIS FACTOR BLOCKERS IN ADULT’S AND CHILDREN’S RHEUMATOLOGIC PRACTICE

T.M. Bzarova; E.I. Alexeeva; S.I. Valieva; A.M. Alekseeva; R.V. Denisova; K.B. Isaeva

Вопросы современной педиатрии (Jan 2010)

SAFETY OF TUMOR NECROSIS FACTOR BLOCKERS IN ADULT’S AND CHILDREN’S RHEUMATOLOGIC PRACTICE

T.M. Bzarova,
E.I. Alexeeva,
S.I. Valieva,
A.M. Alekseeva,
R.V. Denisova,
K.B. Isaeva

Affiliations

T.M. Bzarova: Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
E.I. Alexeeva: Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
S.I. Valieva: Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
A.M. Alekseeva: Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
R.V. Denisova: Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
K.B. Isaeva: Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow

Journal volume & issue: Vol. 9, no. 1
pp. 82 – 94

Abstract

Read online

The article presents the review of a safety of TNF blockers in treatment of rheumatologic diseases in adults and children. Authors give a data on separate, open-labeled, and multicenter double-blinded placebo-controlled studies of tolerance to infliximab, etanercept and adalimumab. The results of studies show high effectiveness and good safety of TNF blockers in adult’s and children’s rheumatologic practice. Key words: children, rheumatoid arthritis, juvenile arthritis, TNF blockers, treatment, safety, infliximab, adalimumab, etanercept.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(1):82-94)

Published in Вопросы современной педиатрии

ISSN: 1682-5527 (Print); 1682-5535 (Online)
Publisher: "Paediatrician" Publishers LLC
Country of publisher: Russian Federation
LCC subjects: Medicine: Pediatrics
Website: https://vsp.spr-journal.ru

About the journal